Abstract
Acquired bacterial resistance is currently one of the causes of mortality and morbidity from infectious diseases. Mathematical modeling allows us to predict the further spread of resistance and to some extent to control its dynamics. The purpose of this review is to find and analyze the existing mathematical models in order to understand all the pros and cons of current approaches to collecting and processing the data. During the analysis, 7 articles about mathematical approaches to the studying of resistance that satisfy the inclusion / exclusion criteria were selected. All models were classified according to the approach used to studying resistance in the presence of the antibiotic. Three main classes and one additional class were allocated. Class #1 consists of two models which include the parameter responsible for the effect of the antibiotic as the defined daily dosage (DDD). These models are characterized by similar mathematical approaches (time series analysis and regression). Class #2 consists of one model where the effect of the antibiotic is presented as the fraction of patients treated with this antibiotic and the process is described with differential equations. Class #3 consists of two models: the effect of the antibiotic is estimated via the antibiotic dose as the degree of growth inhibition. The process is described in detail with differential equations from a biological standpoint. Class #4 is optional and consists of models that are interesting not so much in terms of mathematical approaches but in terms of the obtained results. All models are analyzed within classes and their pros and cons in terms of our research are identified. Each of the described models can be used on our data, though some models require certain modifications due to the specifics of the research.

1.
Spellberg B., Guidos R., Gilbert D., et al. The epidemic of antibioticresistant infections: a call to action for the medical community from the Infectious Diseases Society of America. Clin Infect Dis 2008; 46(2): 15564.

2.
Macgowan A.P.; BSAC Working Parties on Resistance Surveillance. Clinical implications of antimicrobial resistance for therapy. J Antimicrob Chemother 2008; 62 Suppl 2:ii10514.

3.
Schwaber M.J., Carmeli Y. Mortality and delay in effective therapy associated with extendedspectrum betalactamase production in Enterobacteriaceae bacteraemia: a systematic review and metaanalysis. J Antimicrob Chemother 2007; 60(5):91320.

4.
Whitby M., McLaws M.L., Berry G. Risk of death from methicillinresistant Staphylococcus aureus bacteraemia: a metaanalysis. Med J Aust 2001;175(5):2647.

5.
Lee B.Y., Yilmaz S.L., Wong K.F., et al. Modeling the regional spread and control of vancomycinresistant enterococci. Am J Infect Control 2013;41(8):66873.

6.
Worby C.J., Jeyaratnam D., Robotham J.V., et al. Estimating the effectiveness of isolation and decolonization measures in reducing transmission of methicillinresistant Staphylococcus aureus in hospital general wards. Am J Epidemiol 2013;177(11):130613.

7.
Bootsma M.C., van der Horst M.A., Guryeva T., et al. Modeling noninherited antibiotic resistance. Bull Math Biol 2012; 74(8):1691705.

8.
Banks H.T., Hu S., Joyner M., et al. A comparison of computational efficiencies of stochastic algorithms in terms of two infection models. Math Biosci Eng 2012; 9(3):487526.

9.
Chamchod F., Ruan S. Modeling methicillinresistant Staphylococcus aureus in hospitals: transmission dynamics, antibiotic usage and its history. Theor Biol Med Model 2012; 9:25.

10.
Yahdi M., Abdelmageed S., Lowden J., et al. Vancomycinresistant enterococci colonizationinfection model: parameter impacts and outbreak risks. J Biol Dyn 2012; 6(2):64562.

11.
Chamchod F., Ruan S. Modeling the spread of methicillinresistant Staphylococcus aureus in nursing homes for elderly. PLoS One 2012; 7(1):e29757.

12.
Wang J., Wang L., Magal P., et al. Modelling the transmission dynamics of meticillinresistant Staphylococcus aureus in Beijing Tongren hospital. J Hosp Infect 2011; 79(4):3028.

13.
KardasSloma L., Boëlle P.Y., Opatowski L., et al. Impact of antibiotic exposure patterns on selection of communityassociated methicillinresistant Staphylococcus aureus in hospital settings. Antimicrob Agents Chemother 2011; 55(10):488895.

14.
Artalejo J.R., Economou A., LopezHerrero M.J., et al. On the number of recovered individuals in the SIS and SIR stochastic epidemic models. Math Biosci 2010; 228(1):4555.

15.
Webb G.F., D’Agata E.M., Magal P., et al. A model of antibioticresistant bacterial epidemics in hospitals. Proc Natl Acad Sci U S A 2005; 102(37):133438.

16.
Aldrin M., Raastad R., Tvete I.F., et al. Antibiotic resistance in hospitals: a wardspecific random effect model in a low antibiotic consumption environment. Stat Med 2013; 32(8):140718.

17.
Karlsson D. Probabilistic network modelling of the impact of penicillin consumption on spread of pneumococci. Epidemiol Infect 2011; 139(9):135160.

18.
D’Agata E.M., Webb G., Horn M., et al. A mathematical model quantifying the impact of antibiotic exposure and other interventions on the endemic prevalence of vancomycinresistant enterococci. J Infect Dis 2005; 192(11):200411.

19.
Friedman A., Ziyadi N., Boushaba K., et al. A model of drug resistance with infection by health care workers. Math Biosci Eng 2010; 7(4):77992.

20.
D’Agata E.M., DupontRouzeyrol M., Magal P., et al. The impact of different antibiotic regimens on the emergence of antimicrobialresistant bacteria. PLoS One 2008; 3(12):e4036.

21.
Sun L., Klein E.Y., Laxminarayan R. Seasonality and temporal correlation between community antibiotic use and resistance in the United States. Clin Infect Dis 2012; 55(5):68794.

22.
Geli P., Rolfhamre P., Almeida J., et al. Modeling pneumococcal resistance to penicillin in southern Sweden using artificial neural networks. Microb Drug Resist 2006; 12(3):14957.